Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

In case you didn’t pay attention, and you’re completely excused if you didn’t, the Democrats had an election over the weekend ...

Niktimvo marks the first FDA-approved therapy targeting CSF-1R to address inflammation and fibrosis in chronic graft-versus-host disease ... or 3.0 mg/kg every four weeks. The primary endpoint of the ...

As such, while the anti-graft agency and the judiciary appear ... In reminding judges of their key position in the success or failure of the society, Justice Kudirat Kekere-Ekun noted that there ...

INCY has delivered a good performance in the past year on positive data readouts and encouraging pipeline progress. We believe there is room for further growth at current levels.

The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

Delhi’s voters dismissed the AAP from office, signaling approval of the BJP’s relentless targeting of the opposition party.

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

We noted that metabolic dysfunction was not associated with ≥F3 ... Furthermore, SLG is known to be associated with primary graft non-function and poor post-LT outcomes, including graft loss, ...

Heart failure was listed as a contributing or primary cause of death on more than 450,000 death ... tiny patches that could ...

Gene profiling and intercellular communication analysis identified natural killer cells as the primary source of interferon-γ ... an essential role in the development of rejection and graft ...